Transfusion hemosiderosis
| Transfusion hemosiderosis | |
|---|---|
| Classification and external resources | |
| Specialty | emergency medicine |
| ICD-10 | T80.8 |
| ICD-9-CM | 999.8 |
Transfusional hemosiderosis is the accumulation of iron in the liver and/or heart but also endocrine organs, in patients who receive frequent blood transfusions (such as those with thalassemia, sickle cell disease, aplastic anemia or myelodysplastic syndrome).
Treatment
Treatment is by chelation therapy with iron chelating agents such as deferoxamine, deferiprone or deferasirox.[1] If iron overload has caused end-organ damage, this is generally irreversible and may require transplantation.
Notable patients
Ted DeVita died of transfusional iron overload from too many blood transfusions.
See also
References
- ↑ Hider, Robert C.; Kong, Xiaole (2013). "Chapter 8. Iron: Effect of Overload and Deficiency". In Astrid Sigel, Helmut Sigel and Roland K. O. Sigel. Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences 13. Springer. pp. 229–294. doi:10.1007/978-94-007-7500-8_8.
2. Lu JP, Hayashi K. Selective iron deposition in pancreatic islet B cells of transfusional iron-overloaded autopsy cases. Pathol Int. 1994 Mar;44(3):194-9.PubMed PMID 8025661.
| ||||||||||||||
This article is issued from Wikipedia - version of the Friday, January 16, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.